262 related articles for article (PubMed ID: 22916018)
1. Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection.
Delgado T; Sanchez EL; Camarda R; Lagunoff M
PLoS Pathog; 2012; 8(8):e1002866. PubMed ID: 22916018
[TBL] [Abstract][Full Text] [Related]
2. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
3. Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival.
Sanchez EL; Carroll PA; Thalhofer AB; Lagunoff M
PLoS Pathog; 2015 Jul; 11(7):e1005052. PubMed ID: 26197457
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL is required to protect endothelial cells latently infected with KSHV from virus induced intrinsic apoptosis.
Moore LN; Holmes DL; Sharma A; Landazuri Vinueza J; Lagunoff M
PLoS Pathog; 2023 May; 19(5):e1011385. PubMed ID: 37163552
[TBL] [Abstract][Full Text] [Related]
6. Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism.
Sychev ZE; Hu A; DiMaio TA; Gitter A; Camp ND; Noble WS; Wolf-Yadlin A; Lagunoff M
PLoS Pathog; 2017 Mar; 13(3):e1006256. PubMed ID: 28257516
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
Yogev O; Lagos D; Enver T; Boshoff C
PLoS Pathog; 2014 Sep; 10(9):e1004400. PubMed ID: 25255370
[TBL] [Abstract][Full Text] [Related]
8. Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.
Lagunoff M
Curr Opin Virol; 2016 Aug; 19():45-9. PubMed ID: 27434732
[TBL] [Abstract][Full Text] [Related]
9. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.
Holmes DL; Vogt DT; Lagunoff M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441
[TBL] [Abstract][Full Text] [Related]
10. Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes.
DiMaio TA; Gutierrez KD; Lagunoff M
PLoS Pathog; 2011 Dec; 7(12):e1002424. PubMed ID: 22174684
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
[TBL] [Abstract][Full Text] [Related]
12. Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells.
Delgado T; Carroll PA; Punjabi AS; Margineantu D; Hockenbery DM; Lagunoff M
Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10696-701. PubMed ID: 20498071
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
14. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
15. SIRT1-mediated downregulation of p27Kip1 is essential for overcoming contact inhibition of Kaposi's sarcoma-associated herpesvirus transformed cells.
He M; Yuan H; Tan B; Bai R; Kim HS; Bae S; Che L; Kim JS; Gao SJ
Oncotarget; 2016 Nov; 7(46):75698-75711. PubMed ID: 27708228
[TBL] [Abstract][Full Text] [Related]
16. Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.
Lee MS; Jones T; Song DY; Jang JH; Jung JU; Gao SJ
PLoS Pathog; 2014 Sep; 10(9):e1004412. PubMed ID: 25254972
[TBL] [Abstract][Full Text] [Related]
17. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
18. Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.
Dai L; Chen Y; Bonstaff K; Doyle L; Toole B; Parsons C; Qin Z
Cancer Lett; 2015 Jul; 362(2):158-66. PubMed ID: 25837851
[TBL] [Abstract][Full Text] [Related]
19. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
